Migliaccio & Rathod LLP is investigating whether gummy supplements marketed with “GLP-1” claims mislead consumers about their ability to suppress appetite, support weight loss, or increase the body’s GLP-1 levels.
As prescription GLP-1 medications have grown in popularity, a wave of gummy supplements has appeared using “GLP-1” in their names and marketing. Consumers report purchasing these gummies based on:
- “GLP-1 support” or “GLP-1 booster” representations
- Claims of appetite control, metabolism support, and weight loss
- Marketing that suggests the products work like, or as an alternative to, prescription GLP-1 drugs
Prescription GLP-1 medications have been studied in clinical trials. Dietary supplement gummies generally have not been studied as finished products at the doses they contain. If marketing suggests results that are not supported by reliable scientific evidence, consumers may have paid for benefits they did not receive.
Potential concerns may include:
- Unsubstantiated weight-loss and appetite claims
- Implied comparisons to prescription medications
- Price-premium injury
Signs You May Be Affected:
- You purchased a gummy supplement marketed with “GLP-1” claims;
- The product did not lead to the appetite suppression or weight loss advertised;
- You would not have purchased the product had you known its claims might not be supported by reliable scientific evidence.
Potential Claims May Include:
- Violations of state consumer protection laws;
- False advertising;
- Breach of express warranty;
- Unjust enrichment.
If you purchased a GLP-1 gummy supplement, Migliaccio & Rathod LLP would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) 470-3520.